SG11202105662SA - Aptamers against imatinib - Google Patents
Aptamers against imatinibInfo
- Publication number
- SG11202105662SA SG11202105662SA SG11202105662SA SG11202105662SA SG11202105662SA SG 11202105662S A SG11202105662S A SG 11202105662SA SG 11202105662S A SG11202105662S A SG 11202105662SA SG 11202105662S A SG11202105662S A SG 11202105662SA SG 11202105662S A SG11202105662S A SG 11202105662SA
- Authority
- SG
- Singapore
- Prior art keywords
- aptamers against
- against imatinib
- imatinib
- aptamers
- Prior art date
Links
- 108091023037 Aptamer Proteins 0.000 title 1
- 239000005517 L01XE01 - Imatinib Substances 0.000 title 1
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 title 1
- 229960002411 imatinib Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/548—Carbohydrates, e.g. dextran
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/13—Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1819580.0A GB201819580D0 (en) | 2018-11-30 | 2018-11-30 | Aptamers against IMATINIB |
PCT/GB2019/053353 WO2020109791A1 (en) | 2018-11-30 | 2019-11-27 | Aptamers against imatinib |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202105662SA true SG11202105662SA (en) | 2021-06-29 |
Family
ID=65024752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202105662SA SG11202105662SA (en) | 2018-11-30 | 2019-11-27 | Aptamers against imatinib |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220112499A1 (en) |
EP (1) | EP3887523A1 (en) |
JP (1) | JP2022509310A (en) |
KR (1) | KR20210097176A (en) |
CN (1) | CN113710803A (en) |
AU (1) | AU2019387157A1 (en) |
BR (1) | BR112021010418A2 (en) |
CA (1) | CA3121228A1 (en) |
GB (1) | GB201819580D0 (en) |
IL (1) | IL283501A (en) |
SG (1) | SG11202105662SA (en) |
WO (1) | WO2020109791A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023100898A1 (en) * | 2021-12-02 | 2023-06-08 | 株式会社デンソー | Binding substance and analysis method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10336809B4 (en) | 2003-08-07 | 2007-08-02 | Charité - Universitätsmedizin Berlin | ECG system for the large-area measurement of ECG signals |
-
2018
- 2018-11-30 GB GBGB1819580.0A patent/GB201819580D0/en not_active Ceased
-
2019
- 2019-11-27 KR KR1020217020431A patent/KR20210097176A/en unknown
- 2019-11-27 CN CN201980090826.2A patent/CN113710803A/en active Pending
- 2019-11-27 BR BR112021010418-6A patent/BR112021010418A2/en not_active IP Right Cessation
- 2019-11-27 WO PCT/GB2019/053353 patent/WO2020109791A1/en active Application Filing
- 2019-11-27 CA CA3121228A patent/CA3121228A1/en not_active Abandoned
- 2019-11-27 AU AU2019387157A patent/AU2019387157A1/en not_active Abandoned
- 2019-11-27 SG SG11202105662SA patent/SG11202105662SA/en unknown
- 2019-11-27 JP JP2021531231A patent/JP2022509310A/en active Pending
- 2019-11-27 US US17/297,599 patent/US20220112499A1/en active Pending
- 2019-11-27 EP EP19816413.9A patent/EP3887523A1/en active Pending
-
2021
- 2021-05-27 IL IL283501A patent/IL283501A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2019387157A1 (en) | 2021-07-08 |
CA3121228A1 (en) | 2020-06-04 |
EP3887523A1 (en) | 2021-10-06 |
WO2020109791A1 (en) | 2020-06-04 |
GB201819580D0 (en) | 2019-01-16 |
CN113710803A (en) | 2021-11-26 |
JP2022509310A (en) | 2022-01-20 |
KR20210097176A (en) | 2021-08-06 |
US20220112499A1 (en) | 2022-04-14 |
IL283501A (en) | 2021-07-29 |
BR112021010418A2 (en) | 2021-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3467457T3 (en) | Vibrationssensor | |
CA185383S (en) | Casque | |
CA185384S (en) | Casque | |
CA185382S (en) | Casque | |
CA185385S (en) | Casque | |
DK3554057T3 (en) | Audioheadsetsystem | |
DK3372911T3 (en) | Integration af laboratorieventilation | |
DK3613739T3 (en) | Integrin-antagonister | |
DK3753395T3 (en) | Indvendigt luftstyringssystem | |
CA184991S (en) | Uroflowmeter | |
DK3633783T3 (en) | Universal-powerbank | |
CA184993S (en) | Uroflowmeter | |
GB201710451D0 (en) | Comford aid | |
DK3650069T3 (en) | Trakeostomiventil | |
IL283501A (en) | Aptamers against imatinib | |
DK3570498T3 (en) | Adaptivt hvac-styresystem | |
DK3674425T3 (en) | Stålwire | |
CA187782S (en) | Pompon-maker | |
DK3542617T3 (en) | Etikette | |
GB201820913D0 (en) | St | |
GB201813992D0 (en) | St | |
GB201813486D0 (en) | st | |
GB201813476D0 (en) | st | |
GB201813347D0 (en) | St | |
GB201813206D0 (en) | St |